Degarelix and its therapeutic potential in the treatment of prostate cancer.

Clinical interventions in aging

Volumn 4, Issue , 2009, Pages 215-223

  Doehn, Christian ^a   Sommerauer, Martin ^a   Jocham, Dieter ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL 2 NAPHTHYLALANYL 3 CHLOROPHENYLALANYL 1 OXOHEXADECYL SERYL 4 AMINOPHENYLALANYL(HYDROOROTYL) 4 AMINOPHENYLALANYL(CARBAMOYL) LEUCYL ILYS PROLYL ALANINAMIDE; ACETYL-2-NAPHTHYLALANYL-3-CHLOROPHENYLALANYL-1-OXOHEXADECYL-SERYL-4-AMINOPHENYLALANYL(HYDROOROTYL)-4-AMINOPHENYLALANYL(CARBAMOYL)-LEUCYL-ILYS-PROLYL-ALANINAMIDE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; OLIGOPEPTIDE;

AGED; DRUG TOXICITY; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; REVIEW;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; DRUG TOXICITY; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

MLCS; MLOWN;

EID: 71449097742     PISSN: None     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/cia.s3503     Document Type: Review

References (32)